TiGenix (Spain)

TiGenix (Spain)

TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for TiGenix (Spain), Spain, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

81%


Total
Publications

130


Total Open
Publications

105


Total
Citations

3.4K


Open Access
Percentage

81%


Total
Publications

130


Total Open
Publications

105


Total
Citations

3.4K

Wikipedia

Website

download

Breakdown

32% 40% 9% 19%

Publisher Open

32%

Both

40%

Other Platform Open

9%

Closed

19%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

48%OA Journal

OA Journal 48%

45

Hybrid 20%

19

No Guarantees 32%

30

Other Platform Open

Domain 65%

41

Institution 37%

23

Other Internet 27%

17

Public 24%

15

Preprint 11%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
40
Europe PMC
Domain
32
Semantic Scholar
Public
13
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
12
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
3
Research Square
Preprint
3
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
3
Le Centre pour la Communication Scientifique Directe - HAL - Archive ouverte HAL
Institution
3
Zenodo
Public
2
University of Malta - OAR@UM
Institution
2
1 / 4

Data updated 17 June 2024

Share

Share

Share